HOME › DRUGS › VELAGLUCERASE ALFA
ACTIVE SUBSTANCE / INN

VELAGLUCERASE ALFA

Brand name(s): VPRIV, Vpriv
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Gaucher Disease
BLA022575
ACTIVE SUBSTANCE
Velaglucerase Alfa
REGULATORS
FDA · EMA
SPONSORS / MAH
Takeda Pharmaceuticals International AG Ireland Branch, SHIRE HUMAN GENETIC
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VPRIVBLA022575SHIRE HUMAN GENETICPrescription
VPRIVBLA022575SHIRE HUMAN GENETICDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VprivTakeda Pharmaceuticals International AG Ireland BranchAuthorised26/08/2010Gaucher Disease

FULL INTELLIGENCE ON VELAGLUCERASE ALFA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →